ID   M4K1_HUMAN              Reviewed;         833 AA.
AC   Q92918;
DT   28-MAR-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1997, sequence version 1.
DT   12-OCT-2022, entry version 201.
DE   RecName: Full=Mitogen-activated protein kinase kinase kinase kinase 1;
DE            EC=2.7.11.1 {ECO:0000269|PubMed:8824585};
DE   AltName: Full=Hematopoietic progenitor kinase;
DE   AltName: Full=MAPK/ERK kinase kinase kinase 1;
DE            Short=MEK kinase kinase 1;
DE            Short=MEKKK 1;
GN   Name=MAP4K1; Synonyms=HPK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000312|EMBL:AAB97983.1};
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY,
RP   TISSUE SPECIFICITY, AND INTERACTION WITH MAP3K1.
RC   TISSUE=Fetal liver;
RX   PubMed=8824585; DOI=10.1101/gad.10.18.2251;
RA   Hu M.C.-T., Qiu W.R., Wang X., Meyer C.F., Tan T.-H.;
RT   "Human HPK1, a novel human hematopoietic progenitor kinase that activates
RT   the JNK/SAPK kinase cascade.";
RL   Genes Dev. 10:2251-2264(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-421 AND SER-586, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-405; SER-407; SER-413 AND
RP   SER-421, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [6]
RP   VARIANTS [LARGE SCALE ANALYSIS] THR-312; SER-351; LEU-361 AND PHE-737.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [7]
RP   FUNCTION, PHOSPHORYLATION AT THR-165; SER-171; THR-175 AND THR-355,
RP   UBIQUITINATION, MUTAGENESIS OF THR-355, AND INTERACTION WITH FBXW8.
RX   PubMed=24362026; DOI=10.1074/jbc.m113.520106;
RA   Wang H., Chen Y., Lin P., Li L., Zhou G., Liu G., Logsdon C., Jin J.,
RA   Abbruzzese J.L., Tan T.H., Wang H.;
RT   "The CUL7/F-box and WD repeat domain containing 8 (CUL7/Fbxw8) ubiquitin
RT   ligase promotes degradation of hematopoietic progenitor kinase 1.";
RL   J. Biol. Chem. 289:4009-4017(2014).
CC   -!- FUNCTION: Serine/threonine-protein kinase, which may play a role in the
CC       response to environmental stress (PubMed:24362026). Appears to act
CC       upstream of the JUN N-terminal pathway (PubMed:8824585). May play a
CC       role in hematopoietic lineage decisions and growth regulation
CC       (PubMed:8824585, PubMed:24362026). Able to autophosphorylate
CC       (PubMed:8824585). Together with CLNK, it enhances CD3-triggered
CC       activation of T-cells and subsequent IL2 production (By similarity).
CC       {ECO:0000250|UniProtKB:P70218, ECO:0000269|PubMed:24362026,
CC       ECO:0000269|PubMed:8824585}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000269|PubMed:8824585};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000269|PubMed:8824585};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:8824585};
CC   -!- SUBUNIT: Interacts with MAP3K1 (PubMed:8824585). Interacts with FBXW8
CC       (PubMed:24362026). Interacts with CLNK (via its SH2 domain) (By
CC       similarity). {ECO:0000250|UniProtKB:P70218,
CC       ECO:0000269|PubMed:24362026, ECO:0000269|PubMed:8824585}.
CC   -!- INTERACTION:
CC       Q92918; P00519: ABL1; NbExp=3; IntAct=EBI-881, EBI-375543;
CC       Q92918; P46108: CRK; NbExp=4; IntAct=EBI-881, EBI-886;
CC       Q92918; P46109: CRKL; NbExp=5; IntAct=EBI-881, EBI-910;
CC       Q92918; P06241: FYN; NbExp=2; IntAct=EBI-881, EBI-515315;
CC       Q92918; P62993: GRB2; NbExp=9; IntAct=EBI-881, EBI-401755;
CC       Q92918; P08238: HSP90AB1; NbExp=4; IntAct=EBI-881, EBI-352572;
CC       Q92918; P16333: NCK1; NbExp=4; IntAct=EBI-881, EBI-389883;
CC       Q92918; P27986: PIK3R1; NbExp=2; IntAct=EBI-881, EBI-79464;
CC       Q92918; P19174: PLCG1; NbExp=6; IntAct=EBI-881, EBI-79387;
CC       Q92918; Q13291: SLAMF1; NbExp=3; IntAct=EBI-881, EBI-4315002;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q92918-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q92918-2; Sequence=VSP_040340;
CC   -!- TISSUE SPECIFICITY: Expressed primarily in hematopoietic organs,
CC       including bone marrow, spleen and thymus. Also expressed at very low
CC       levels in lung, kidney, mammary glands and small intestine.
CC       {ECO:0000269|PubMed:8824585}.
CC   -!- PTM: Autophosphorylates: phosphorylation promotes ubiquitination by the
CC       Cul7-RING(FBXW8) ubiquitin-protein ligase complex, leading to its
CC       degradation by the proteasome. {ECO:0000269|PubMed:24362026}.
CC   -!- PTM: Tyrosine-phosphorylated after activation of hemopoietic cells.
CC       {ECO:0000250|UniProtKB:P70218}.
CC   -!- PTM: Ubiquitinated by the Cul7-RING(FBXW8) ubiquitin-protein ligase
CC       complex following autophosphorylation, leading to its degradation by
CC       the proteasome. {ECO:0000269|PubMed:24362026}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. STE20 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U66464; AAB97983.1; -; mRNA.
DR   EMBL; AC005933; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC008649; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS42564.1; -. [Q92918-2]
DR   CCDS; CCDS59385.1; -. [Q92918-1]
DR   RefSeq; NP_001036065.1; NM_001042600.2. [Q92918-2]
DR   RefSeq; NP_009112.1; NM_007181.5. [Q92918-1]
DR   PDB; 6CQD; X-ray; 2.12 A; A/B=2-293.
DR   PDB; 6CQE; X-ray; 1.89 A; A/B=2-293.
DR   PDB; 6CQF; X-ray; 2.25 A; A=2-293.
DR   PDB; 6NFY; X-ray; 2.17 A; A/B=10-307.
DR   PDB; 6NFZ; X-ray; 2.97 A; A/B=1-307.
DR   PDB; 6NG0; X-ray; 2.05 A; A/B=1-307.
DR   PDB; 7KAC; X-ray; 1.85 A; A/B=1-319.
DR   PDB; 7L24; X-ray; 2.68 A; A/B/C/D=7-294.
DR   PDB; 7L25; X-ray; 1.85 A; A/B=6-294.
DR   PDB; 7L26; X-ray; 2.30 A; A/B/C/D=8-294.
DR   PDB; 7M0K; X-ray; 2.01 A; A/B/C/D=6-294.
DR   PDB; 7M0L; X-ray; 2.43 A; A/B/C/D=5-294.
DR   PDB; 7M0M; X-ray; 1.93 A; A/B=2-294.
DR   PDB; 7R9L; X-ray; 2.33 A; A=2-293.
DR   PDB; 7R9N; X-ray; 1.50 A; A/B=2-293.
DR   PDB; 7R9P; X-ray; 2.27 A; A/B=2-293.
DR   PDB; 7R9T; X-ray; 2.00 A; A/B=2-293.
DR   PDB; 7SIU; X-ray; 1.79 A; A/B=2-295.
DR   PDBsum; 6CQD; -.
DR   PDBsum; 6CQE; -.
DR   PDBsum; 6CQF; -.
DR   PDBsum; 6NFY; -.
DR   PDBsum; 6NFZ; -.
DR   PDBsum; 6NG0; -.
DR   PDBsum; 7KAC; -.
DR   PDBsum; 7L24; -.
DR   PDBsum; 7L25; -.
DR   PDBsum; 7L26; -.
DR   PDBsum; 7M0K; -.
DR   PDBsum; 7M0L; -.
DR   PDBsum; 7M0M; -.
DR   PDBsum; 7R9L; -.
DR   PDBsum; 7R9N; -.
DR   PDBsum; 7R9P; -.
DR   PDBsum; 7R9T; -.
DR   PDBsum; 7SIU; -.
DR   AlphaFoldDB; Q92918; -.
DR   SMR; Q92918; -.
DR   BioGRID; 116354; 87.
DR   DIP; DIP-31019N; -.
DR   IntAct; Q92918; 68.
DR   MINT; Q92918; -.
DR   STRING; 9606.ENSP00000465039; -.
DR   BindingDB; Q92918; -.
DR   ChEMBL; CHEMBL5749; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugCentral; Q92918; -.
DR   iPTMnet; Q92918; -.
DR   PhosphoSitePlus; Q92918; -.
DR   BioMuta; MAP4K1; -.
DR   DMDM; 29427916; -.
DR   EPD; Q92918; -.
DR   jPOST; Q92918; -.
DR   MassIVE; Q92918; -.
DR   MaxQB; Q92918; -.
DR   PaxDb; Q92918; -.
DR   PeptideAtlas; Q92918; -.
DR   PRIDE; Q92918; -.
DR   ProteomicsDB; 75603; -. [Q92918-1]
DR   ProteomicsDB; 75604; -. [Q92918-2]
DR   Antibodypedia; 2067; 580 antibodies from 39 providers.
DR   DNASU; 11184; -.
DR   Ensembl; ENST00000396857.7; ENSP00000380066.1; ENSG00000104814.13. [Q92918-2]
DR   Ensembl; ENST00000591517.5; ENSP00000465039.1; ENSG00000104814.13. [Q92918-1]
DR   Ensembl; ENST00000634395.1; ENSP00000489001.1; ENSG00000282928.2. [Q92918-1]
DR   Ensembl; ENST00000634494.2; ENSP00000489158.1; ENSG00000282928.2. [Q92918-2]
DR   GeneID; 11184; -.
DR   KEGG; hsa:11184; -.
DR   MANE-Select; ENST00000396857.7; ENSP00000380066.1; NM_001042600.3; NP_001036065.1. [Q92918-2]
DR   UCSC; uc002oix.3; human. [Q92918-1]
DR   CTD; 11184; -.
DR   DisGeNET; 11184; -.
DR   GeneCards; MAP4K1; -.
DR   HGNC; HGNC:6863; MAP4K1.
DR   HPA; ENSG00000104814; Tissue enhanced (intestine, lymphoid tissue).
DR   MIM; 601983; gene.
DR   neXtProt; NX_Q92918; -.
DR   OpenTargets; ENSG00000104814; -.
DR   PharmGKB; PA30609; -.
DR   VEuPathDB; HostDB:ENSG00000104814; -.
DR   eggNOG; KOG0576; Eukaryota.
DR   GeneTree; ENSGT00940000160308; -.
DR   InParanoid; Q92918; -.
DR   OMA; FLCCALD; -.
DR   OrthoDB; 996262at2759; -.
DR   PhylomeDB; Q92918; -.
DR   TreeFam; TF105121; -.
DR   PathwayCommons; Q92918; -.
DR   SignaLink; Q92918; -.
DR   SIGNOR; Q92918; -.
DR   BioGRID-ORCS; 11184; 14 hits in 1105 CRISPR screens.
DR   ChiTaRS; MAP4K1; human.
DR   GeneWiki; MAP4K1; -.
DR   GenomeRNAi; 11184; -.
DR   Pharos; Q92918; Tchem.
DR   PRO; PR:Q92918; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q92918; protein.
DR   Bgee; ENSG00000104814; Expressed in granulocyte and 99 other tissues.
DR   ExpressionAtlas; Q92918; baseline and differential.
DR   Genevisible; Q92918; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0008349; F:MAP kinase kinase kinase kinase activity; IDA:UniProtKB.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0008283; P:cell population proliferation; IMP:UniProtKB.
DR   GO; GO:1904628; P:cellular response to phorbol 13-acetate 12-myristate; IDA:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0007254; P:JNK cascade; IDA:UniProtKB.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IDA:UniProtKB.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; IDA:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   InterPro; IPR001180; CNH_dom.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR021160; MAPKKKK.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   Pfam; PF00780; CNH; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   PIRSF; PIRSF038172; MAPKKKK; 1.
DR   SMART; SM00036; CNH; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50219; CNH; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Kinase;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase; Ubl conjugation.
FT   CHAIN           1..833
FT                   /note="Mitogen-activated protein kinase kinase kinase
FT                   kinase 1"
FT                   /id="PRO_0000086273"
FT   DOMAIN          17..274
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          495..800
FT                   /note="CNH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00795"
FT   REGION          296..478
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        299..313
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        333..347
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        389..405
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        432..446
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        137
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         23..31
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         46
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         165
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:24362026"
FT   MOD_RES         171
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:24362026"
FT   MOD_RES         175
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:24362026"
FT   MOD_RES         355
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:24362026"
FT   MOD_RES         374
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P70218"
FT   MOD_RES         376
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P70218"
FT   MOD_RES         405
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332"
FT   MOD_RES         407
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332"
FT   MOD_RES         413
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332"
FT   MOD_RES         421
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19369195,
FT                   ECO:0007744|PubMed:19690332"
FT   MOD_RES         586
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19369195"
FT   VAR_SEQ         800..833
FT                   /note="LECSGTISPHCNLLLPGSSNSPASASRVAGITGL -> PVVVETRPVDDPTA
FT                   PSNLYIQE (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_040340"
FT   VARIANT         312
FT                   /note="P -> T (in dbSNP:rs55924696)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040739"
FT   VARIANT         351
FT                   /note="P -> S (in dbSNP:rs34591617)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040740"
FT   VARIANT         361
FT                   /note="P -> L (in dbSNP:rs56060067)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040741"
FT   VARIANT         737
FT                   /note="S -> F (in a metastatic melanoma sample; somatic
FT                   mutation; dbSNP:rs1238066548)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040742"
FT   VARIANT         811
FT                   /note="N -> S (in dbSNP:rs12975825)"
FT                   /id="VAR_051643"
FT   MUTAGEN         355
FT                   /note="T->A: Retains kinase activity. Not degraded by the
FT                   Cul7-RING ubiquitin-protein ligase complex containing
FT                   FBXW8."
FT                   /evidence="ECO:0000269|PubMed:24362026"
FT   STRAND          9..11
FT                   /evidence="ECO:0007829|PDB:7SIU"
FT   HELIX           13..15
FT                   /evidence="ECO:0007829|PDB:7R9N"
FT   STRAND          17..26
FT                   /evidence="ECO:0007829|PDB:7R9N"
FT   STRAND          29..36
FT                   /evidence="ECO:0007829|PDB:7R9N"
FT   TURN            37..39
FT                   /evidence="ECO:0007829|PDB:7R9N"
FT   STRAND          42..49
FT                   /evidence="ECO:0007829|PDB:7R9N"
FT   STRAND          52..54
FT                   /evidence="ECO:0007829|PDB:7L24"
FT   HELIX           57..67
FT                   /evidence="ECO:0007829|PDB:7R9N"
FT   STRAND          77..83
FT                   /evidence="ECO:0007829|PDB:7R9N"
FT   STRAND          86..92
FT                   /evidence="ECO:0007829|PDB:7R9N"
FT   HELIX           99..106
FT                   /evidence="ECO:0007829|PDB:7R9N"
FT   HELIX           111..130
FT                   /evidence="ECO:0007829|PDB:7R9N"
FT   HELIX           140..142
FT                   /evidence="ECO:0007829|PDB:7R9N"
FT   STRAND          143..145
FT                   /evidence="ECO:0007829|PDB:7R9N"
FT   STRAND          151..153
FT                   /evidence="ECO:0007829|PDB:7R9N"
FT   HELIX           157..171
FT                   /evidence="ECO:0007829|PDB:7R9N"
FT   HELIX           176..178
FT                   /evidence="ECO:0007829|PDB:6CQD"
FT   HELIX           181..189
FT                   /evidence="ECO:0007829|PDB:7R9N"
FT   HELIX           196..210
FT                   /evidence="ECO:0007829|PDB:7R9N"
FT   TURN            214..217
FT                   /evidence="ECO:0007829|PDB:7R9N"
FT   HELIX           220..227
FT                   /evidence="ECO:0007829|PDB:7R9N"
FT   TURN            240..242
FT                   /evidence="ECO:0007829|PDB:7R9N"
FT   HELIX           245..254
FT                   /evidence="ECO:0007829|PDB:7R9N"
FT   HELIX           259..261
FT                   /evidence="ECO:0007829|PDB:7R9N"
FT   HELIX           265..268
FT                   /evidence="ECO:0007829|PDB:7R9N"
FT   HELIX           272..275
FT                   /evidence="ECO:0007829|PDB:7R9N"
FT   HELIX           282..292
FT                   /evidence="ECO:0007829|PDB:7R9N"
SQ   SEQUENCE   833 AA;  91296 MW;  3C98CF01BE42E151 CRC64;
     MDVVDPDIFN RDPRDHYDLL QRLGGGTYGE VFKARDKVSG DLVALKMVKM EPDDDVSTLQ
     KEILILKTCR HANIVAYHGS YLWLQKLWIC MEFCGAGSLQ DIYQVTGSLS ELQISYVCRE
     VLQGLAYLHS QKKIHRDIKG ANILINDAGE VRLADFGISA QIGATLARRL SFIGTPYWMA
     PEVAAVALKG GYNELCDIWS LGITAIELAE LQPPLFDVHP LRVLFLMTKS GYQPPRLKEK
     GKWSAAFHNF IKVTLTKSPK KRPSATKMLS HQLVSQPGLN RGLILDLLDK LKNPGKGPSI
     GDIEDEEPEL PPAIPRRIRS THRSSSLGIP DADCCRRHME FRKLRGMETR PPANTARLQP
     PRDLRSSSPR KQLSESSDDD YDDVDIPTPA EDTPPPLPPK PKFRSPSDEG PGSMGDDGQL
     SPGVLVRCAS GPPPNSPRPG PPPSTSSPHL TAHSEPSLWN PPSRELDKPP LLPPKKEKMK
     RKGCALLVKL FNGCPLRIHS TAAWTHPSTK DQHLLLGAEE GIFILNRNDQ EATLEMLFPS
     RTTWVYSINN VLMSLSGKTP HLYSHSILGL LERKETRAGN PIAHISPHRL LARKNMVSTK
     IQDTKGCRAC CVAEGASSGG PFLCGALETS VVLLQWYQPM NKFLLVRQVL FPLPTPLSVF
     ALLTGPGSEL PAVCIGVSPG RPGKSVLFHT VRFGALSCWL GEMSTEHRGP VQVTQVEEDM
     VMVLMDGSVK LVTPEGSPVR GLRTPEIPMT EAVEAVAMVG GQLQAFWKHG VQVWALGSDQ
     LLQELRDPTL TFRLLGSPRL ECSGTISPHC NLLLPGSSNS PASASRVAGI TGL
//
